Detalhe da pesquisa
1.
Clinically Important Benefits and Harms of Monoclonal Antibodies Targeting Amyloid for the Treatment of Alzheimer Disease: A Systematic Review and Meta-Analysis.
Ann Fam Med;
22(1): 50-62, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38253509